Pricing Strategy

We can support you throughout the product life cycle, to develop your list and net pricing strategy.

Strategy

Launch price optimization and strategy

Optimizing the launch price of your product is critical for product success. We work with you to ensure your pricing strategy is aligned with your market access strategy and reflects the perceived payer value of the product.

Payer Value

Indication / asset price potential

  • Payer perceived value (and hence price) of indications varies based on the competitive landscape and perceived added value of your product
  • We can support you in determining the payer value of different indications, or assets, to support your indication sequencing and clinical development prioritization

Considerations

Clinical trial optimization

  • Understanding what clinical attributes drive payer value (and price) is critical for optimizing your clinical development plan
  • We can support you in determining the implications of clinical trial considerations, taking into account the risk/ payer benefit of different trial designs to facilitate clinical trial development that enables both regulatory and HTA approval at a price that represents value to you and healthcare providers

Commercial Success

Preliminary price estimates

Understanding the value of early-stage assets, or potential in/out licensing opportunities enhances commercial decision making based on evidence based price estimates